*****ON THE WATCHLIST FOR NEXT WEEK AS STOCK HAS BEEN ACTING QUITE BULLISH IN RECENT DAYS***** CAMBRIDGE, Mass., May 29, 2019 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (INFI) announced today that members of the management team will be participating in the 2019 BIO International Convention at Pennsylvania Convention Center, Philadelphia, PA. Adelene Perkins,...
*******June is setting up to a very big month for NASDAQ:NVUS and some very profitable trades may on the offering,. Keep track of the notable dates listed below for results and presentations. Accumulation has already began in anticipation of positive news. ********** AVERAGE ANALYSTS PRICE TARGET $8.75 AVERAGE ANALYSTS RECOMMENDATION BUY UPCOMING MARKET...
*******KEEP ON THE WATCHLIST FOR NEXT WEEK, MUCH GREATER MOVES EXPECTED ON MORE NEWS, PURELY SPECULATIVE ***** COMPANY PROFILE Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and...
*****HOT STOCK FRIDAY, KEEP ON THE RADAR FOR MAJOR CONTINUATION IN THE DAYS AND WEEKS TO COME.******** AVERAGE TARGET PRICE $25.67 AVERAGE RECOMMENDATION BUY COMPANY DETAILS Genocea is a biopharmaceutical company developing personalized cancer immunotherapies. Our unique ATLAS™ technology platform allows us to identify immunotherapy targets based on each...
SPECULATION AND RUMORS HAVE PUT THIS STOCK ON THE WATCHLIST FOR THE WEEKS TO COME, HAD A GOOD DAY ON FRIDAY WITH A 7%SPIKE ON GOOD VOLUME, WHICH MAY HAVE BEEN HAMPERED BY THE MARKET SENTIMENT. STOCK HAS SUFFERED RECENTLY FROM A SPLIT AND OFFERING SO WE AWAIT A POSITIVE CATALYST. COMPANY PROFILE Auris Medical Holding Ltd. engages in the development of novel...
******THE STOCK OF NASDAQ:WPRT HAS HAD SOME FANTASTIC PRICE ACTION FOLLOWING A FANTASTIC EARNINGS REPORT WHICH HAS CAPTURED THE ATTENTION OF INVESTORS. LOOK OUT FOR CONTINUATION OF THE TREND TOWARDS $3.60******** RECENT EARNINGS HIGHLIGHTS "Our Q1 2019 results are another validation of our strategy and reflect improved performance across all of our...
***$$$$$$$$$$$$$$$$$$$$$$$ASSOCIATION WITH GOOGLE FOR SUCH A SMALL CAP JUST MEANS $$$$$$$$$$$$$$$$$$$$$* Earnings report Highlights Revenues for the three months ended March 31, 2019 decreased by $0.38 million, or 3%, as compared to the three months ended March 31, 2018, mainly because we did not pursue certain low margin, professional services business during...
The stock of NASDAQ:HYGS was flagged yesterday for its volume and price spike, resulting in a new 3 year high. We are now on the lookout for continuation and a full scale breakout move. COMPANY PROFILE Hydrogenics Corp. designs, develops and manufactures hydrogen generation and fuel cell products based on water electrolysis technology and proton exchange...
*******HOT STOCK TO WATCH , 800,000 SHARES TRADED AFTER HOURS SPIKING THE PRICE 40%, MONSTER MOVES EXPECTED IN THE COMING DAYS.********* Company profile Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in...
*****Keep NASDAQ:ICON on your watch-list for some strong moves in the weeks to come, speculation and rumor have brought this to our attention, in confluence with strong price actions and volume today. SHORT INTEREST $22.40 COMPANY PROFILE Iconix Brand Group, Inc. engages in the ownership, licensing and markets a portfolio of consumer brands is a brand...
OMG this has been a horrible stock for the last year, its dropped so much even bottom feeders won't touch it. There is still a possible 30% for the shorts to gather before this finds a bottom at 2013 levels. If the trade climate changes with China, get into this as quick as you can, it will rocket higher. Remember just because something is cheap doesn't mean its...
*******YOU NEED TO MOVE FAST IN THIS STOCK, ITS ATTRACTING A LOT OF ATTENTION, ALREADY ON A ROLL AND VERY BULLISH SETUP******** Zynga Inc is a US-based company that develops, markets, and operates social games as live services played on mobile platforms, such as iOS and Android, and social networking sites, such as Facebook. Zynga generates revenue through mobile...
******UP PRE MARKET 15% BUT THIS COULD RUN A LOT HIGHER ON THE COMPANIES ANNOUNCEMENT OF RESTRUCTURING AND COST CUTTING, EXTREME RELIEF FOR INVESTORS WHOM WANTED A PRO ACTIVE APPROACH MUCH SOONER. ***** AVERAGE PRICE TARGET $20.50 AVERAGE RECOMMENDATION BUY COMPANY PROFILE electroCore, Inc. is a commercial-stage bio-electronic medicine company, with a platform...
THE CURRENT AVERAGE ANALYSTS PRICE TARGET IS $11.72 WHILE THE STOCK PRICE IS $11.40, THUS ANALYSTS WILL EITHER HAVE TO RAISE OR LOWER, WE ARE OF THE OPINION THAT IT WILL BE A RAISE. NYSE:SNAP HAS ALWAYS CARRIED SPECULATION BUT CURRENT SPECULATION REGARDING THE INTRODUCTION OF MUSIC WOULD BE HUGELY IMPORTANT MOVE FOR SNAP. CONSIDERING THE CORE CUSTOMERS ARE...
Pivotal Research today initiated NYSE:TWTR with a Buy rating and a $48 price target. Twitter should be a real winner in the current environment, given the fact there is a election approaching and it has now become the Media channel of choice for MR Trump, with others likely to use it as a similar platform for their campaigns. TWTR has also no reliance on China...
When options traders make a big bet, it always makes a stock interesting as they are often in the know, recent $30 call option volume has been unusually high in the past few days in NYSE:SIG . Which also makes the stock a possibility for a reversal pop is the high short volume and the fact it may have found some support on 2003 and 2009 levels, YIP that's how bad...
The most recent earnings report blow through estimates, sales in quarter jumped 47% and $5 million above estimates, taking the company closer to profitability, with a loss per share of $.16 which exceeded the $.20 estimate. due to a increase in current client spending the company has raised its guidance once again. This is a high growth sector and under the...
Unfortunately NYSE:YEXT will release earnings in the middle of a sell off, but we are confident that earnings will surprise to the upside, the stock gains will probably be hampered by market sentiment. Yext has become more appealing to the analysts community, SunTrust analysts Naved Khan yesterday reiterated a Buy rating and a $30 target, he wrote “We expect...